. 2018 Aug 24;9(66):32642–32652. doi: 10.18632/oncotarget.25982

Table 2. KRAS^mt/SMAD4^mt and Control cell lines.

Cell line	Group	Cancer type	KRAS	SMAD4	SF₂
AsPC-1	KRAS^mt/SMAD4^mt	pancreatic	G12D	HD	0.66 ± 0.13
PK-1	KRAS^mt/SMAD4^mt	pancreatic	G12D	HD	0.50
SW1990	KRAS^mt/SMAD4^mt	pancreatic	G12D	HD	0.56 ± 0.19
Capan-1	KRAS^mt/SMAD4^mt	pancreatic	G12V	S343*	0.52 ± 0.24
CFPAC-1	KRAS^mt/SMAD4^mt	pancreatic	AMP, G12V	HD	0.58
PSN1	KRAS^mt/SMAD4^mt	pancreatic	AMP, G12R	HD	0.48 ± 0.00
T84	KRAS^mt/SMAD4^mt	colorectal	G12D	HD	0.74 ± 0.28
SW403	KRAS^mt/SMAD4^mt	colorectal	G13V	HD	0.59
SW480	KRAS^mt/SMAD4^mt	colorectal	AMP, G12V	HD	0.67 ± 0.07
SW620	KRAS^mt/SMAD4^mt	colorectal	AMP, G12V	HD	0.59 ± 0.16
AGS	KRAS^mt/SMAD4^mt	stomach	G12D	HD	0.45 ± 0.06
SW1573	KRAS^mt/SMAD4^mt	lung	G12C	HD	0.60 ± 0.08
Capan-2	Control	pancreatic	G12V	WT	0.49 ± 0.04
MIAPaCa-2	Control	pancreatic	G12C	WT	0.49 ± 0.10
PANC-1	Control	pancreatic	AMP	WT	0.73 ± 0.20
HCT 116	Control	colorectal	G13D	WT	0.42 ± 0.10
LoVo	Control	colorectal	G13D	WT	0.38 ± 0.10
LS180	Control	colorectal	G12D	WT	0.50
RKO	Control	colorectal	WT	WT	0.33 ± 0.13
SW48	Control	colorectal	WT	WT	0.22 ± 0.06
NCI-N87	Control	stomach	WT	HD	0.39 ± 0.15
MKN-45	Control	stomach	WT	HD	0.65 ± 0.25
NCI-H1437	Control	lung	WT	WT	0.34
NCI-H1648	Control	lung	WT	WT	0.16

Abbreviations: AMP, amplification; HD, homozygous deletion; WT, wild type. SF₂ data were obtained from previous publications, and the average ± standard deviation (if available) value for each cell line is shown (for details, see Acquisition of SF₂ data from the literature in MATERIALS AND METHODS).

Table 2. KRASmt/SMAD4mt and Control cell lines.

Table 2. KRAS^mt/SMAD4^mt and Control cell lines.